|Articles|March 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Study Shows No Increased Risk of Suicide

New research has attempted to clarify earlier studies connecting older cholesterol- lowering drugs with an increased risk of suicide. The latest study, published recently in the , analyzed data on 94,441 adults in the United Kingdom, including 458 individuals diagnosed with depression and 105 participants who considered, attempted, or committed suicide. The results showed no increased risk for suicidal behavior among adults taking any type of cholesterol-lowering drugs, and depression was less common among the medication users.

For example, approximately 3% of the participants taking statins and 4% of those taking other cholesterol-lowering drugs were depressed, compared with 11% of nonusers of the drugs. Also, the link was strongest among long-term statin users. The researchers hypothesized that cholesterol-lowering drugs might indirectly improve well-being by lowering heart-related ailments and enhancing people?s quality of life. Furthermore, patients on cholesterol-lowering drugs could be more healthconscious and take better care of themselves, "which will further reduce their risk of developing depression," said the study authors.

Articles in this issue

over 21 years ago

New Technologies Top Survey

over 21 years ago

PDX Software Gets High Marks

over 21 years ago

Seal•ON

over 21 years ago

SaltAire Sinus Relief

over 21 years ago

Zim's Crack Creme Hand Sanitizer

over 21 years ago

CoroWise Plant Sterols

over 21 years ago

Culturelle

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME